RESEARCH, TRADITIONS AND SAFETY

Hair loss

The cause of hair loss determines what can help. Small ingredient studies often test a particular lotion or multi-ingredient product. Their findings do not automatically apply to food, oils or supplements with a similar name.

Male-pattern androgenetic alopecia, autoimmune alopecia areata, deficiency-associated shedding and supplement-related harm are separate settings. These are educational references, not a ranked treatment list.

A plain comb beside an open blank reference book
Decorative topic illustration.

Care basics come first

How we chose these entries

Seventeen materials were selected for meaningful human research, nutritional context, common evidence errors or important safety findings. Safety and animal-study records are not treatment recommendations.

No ingredient here has established a general cure for hair loss. Evidence remains weak for many marketed botanicals, long-term effects and male-pattern outcomes. Protein adequacy stays in topic education; the women-only melatonin pilot is excluded. Combination trials were not split into extra single-ingredient claims.

17 reviewed records

Care and risk-reduction research

Read the outcome, preparation and limits. A studied benefit does not make every product effective.

Symptom support

Rosemary essential oil

Antique botanical-style illustration of an amber oil dropper bottle beside a narrow-leaved rosemary sprig.
Ingredient reference illustration: Rosemary essential oil. Studied form: Standardized topical lotion containing at least 3.7 mg/mL 1,8-cineole; not a DIY essential-oil percentage. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Salvia rosmarinus (syn. Rosmarinus officinalis) · Distilled aerial parts

Form
Standardized topical lotion containing at least 3.7 mg/mL 1,8-cineole; not a DIY essential-oil percentage
How it is used
topical
Evidence
Limited clinical evidence; one small active-comparator trial

Both groups’ hair counts increased from baseline at six months; neither improved significantly at three months. No between-group difference was detected. Without a placebo arm or a formal equivalence demonstration, this does not prove equivalence, and it does not compare rosemary with 5% minoxidil.

Condition and setting

androgenetic_alopecia

Cautions

  • Itching occurred in both groups. EMA describes contact dermatitis/hypersensitivity and advises against application to broken or irritated skin. No DIY formulation can be inferred.

Read full ingredient card: Rosemary essential oil

Evidence, limits and sources for Rosemary essential oil

What was found

A lotion standardized to at least 3.7 mg of 1,8-cineole per mL, 1 mL twice daily for six months, compared with 2% minoxidil in a randomized single-blind study of 100 men. This is not a declared essential-oil percentage or 3.7 mg/mL of whole rosemary oil.

What this does not show

Single-blind, no placebo, 2% minoxidil comparator and no formal equivalence design; findings do not validate rosemary water, pure retail oil or a homemade dilution.

Exact ingredient

This is distilled rosemary oil in a specific studied lotion; rosemary leaf preparations are different.

Why we included it

A widely repeated claim needs exact-formulation and comparator correction.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Pumpkin-containing oral combination (Octa Sabal Plus)

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Cucurbita pepo plus other ingredients · Pumpkin seed preparation in a proprietary multi-ingredient capsule

Form
Octa Sabal Plus, described in the paper as supplying pumpkin seed oil; full trial-batch co-ingredient composition incompletely documented
How it is used
oral
Evidence
Limited clinical evidence; small formulation-specific trial

Mean target-area hair count rose approximately 40% versus 10% with placebo; hair-thickness change did not differ. This was a small, supplier-funded trial, not evidence for a 40% restoration of whole-scalp coverage.

Condition and setting

androgenetic_alopecia

Cautions

  • Itching and mild abdominal discomfort were reported; long-term safety and generalizability remain uncertain.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The proprietary combination is different from culinary pumpkin seed oil or whole seeds. A current manufacturer listing does not certify the trial batch.

Evidence, limits and sources for Pumpkin-containing oral combination (Octa Sabal Plus)

What was found

The paper describes 400 mg/day pumpkin seed oil supplied as Octa Sabal Plus capsules for 24 weeks; 76 men with mild-to-moderate AGA were randomized to product or placebo.

What this does not show

A small supplier-funded trial of a branded combination does not isolate pure pumpkin oil. The manufacturer listing is not a trial-batch certificate, and target-area counts are not whole-scalp coverage.

Exact ingredient

The proprietary combination is different from culinary pumpkin seed oil or whole seeds. A current manufacturer listing does not certify the trial batch.

Why we included it

Preserves the real trial while preventing pure-oil attribution.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Saw palmetto fruit extract

Saw palmetto fruit extract
Ingredient reference illustration: Saw palmetto fruit extract. Studied form: Oral extract; the trial abstract does not fully characterize extraction or standardization. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Serenoa repens · Fruit (berries)

Form
Oral extract; the trial abstract does not fully characterize extraction or standardization
How it is used
oral
Evidence
Very limited evidence; NCCIH finds it insufficient for conclusions

Photographic improvement was reported in 38% with saw palmetto versus 68% with finasteride. NCCIH concludes that the small oral/topical hair-loss studies are too limited for a conclusion.

Condition and setting

androgenetic_alopecia

Cautions

  • Digestive symptoms, dizziness, and headache can occur. Discuss use with a clinician when taking medicines; pregnancy/breastfeeding use may be unsafe. Do not describe it as a proven substitute for finasteride.

Read full ingredient card: Saw palmetto fruit extract

Evidence, limits and sources for Saw palmetto fruit extract

What was found

Oral Serenoa repens 320 mg/day versus finasteride 1 mg/day for 24 months in an open-label study of 100 men with mild-to-moderate AGA. The abstract does not sufficiently characterize the extract to equate all retail products.

What this does not show

Open-label comparison and incompletely described extract. Neither whole berries nor topical preparations inherit the result; saw palmetto plus beta-sitosterol trials cannot isolate either ingredient.

Exact ingredient

This refers to a single-herb oral fruit extract, not whole berries or a topical product.

Why we included it

Common marketing claim has sparse and weaker-than-finasteride evidence.

Sources

Symptom support

Apple-derived procyanidin B2

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Isolated apple-derived procyanidin B2

Form
1% procyanidin B2 topical tonic
How it is used
topical
Evidence
Limited clinical evidence; small pilot

Target-area total hair count and certain hair-diameter measures improved relative to placebo. This small pilot does not validate eating apples, apple juice, apple-cider vinegar, or arbitrary oral apple extracts for regrowth.

Condition and setting

androgenetic_alopecia

Cautions

  • No adverse effects were observed in this small study; that does not establish uncommon-event or long-term safety. The authors’ optimistic “cure” language should not be repeated.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The isolated compound in a scalp preparation is different from eating apples.

Evidence, limits and sources for Apple-derived procyanidin B2

What was found

A 1% procyanidin B2 tonic for four months; double-blind study of 29 men, 19 active and 10 placebo.

What this does not show

Small pilot of a topical isolated compound; do not transfer the findings to apple food, vinegar or oral extracts.

Exact ingredient

The isolated compound in a scalp preparation is different from eating apples.

Why we included it

A small human trial of a distinct compound is separable from apple food.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Caffeine-based scalp liquid

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Caffeine incorporated into a manufactured topical product

Form
0.2% caffeine-based Alpecin leave-on liquid, not shampoo or coffee
How it is used
topical
Evidence
Limited clinical evidence; open-label industry-funded trial

The trial met its chosen noninferiority criterion for change in anagen-hair proportion, a hair-cycle endpoint. It did not establish equivalent visible regrowth, hair density, or effectiveness of caffeine shampoo or coffee drinking.

Condition and setting

androgenetic_alopecia

Cautions

  • Open-label design, product-specific formulation, industry involvement, and endpoint selection limit interpretation. The tested topical product should not be replaced with homemade coffee/caffeine preparations.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The studied scalp liquid is different from coffee, beverages or oral caffeine.

Evidence, limits and sources for Caffeine-based scalp liquid

What was found

0.2% caffeine-based Alpecin Liquid, 2 mL twice daily, versus 5% minoxidil solution, 1 mL twice daily, for six months; 210 men randomized in an open-label, manufacturer-funded noninferiority trial.

What this does not show

Open-label, product-specific and industry-funded. The anagen-ratio endpoint does not establish equivalent visible regrowth, density or shampoo efficacy.

Exact ingredient

The studied scalp liquid is different from coffee, beverages or oral caffeine.

Why we included it

Distinguishes a leave-on clinical formulation from shampoos and coffee.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Mixed tocotrienols with alpha-tocopherol

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Mixed tocotrienols plus alpha-tocopherol

Form
Oral softgel combination, not alpha-tocopherol alone
How it is used
oral
Evidence
Limited clinical evidence; small trial with incompletely classified alopecia

Target-area hair number increased by 34.5% versus essentially no change with placebo; hair-clipping weight did not significantly improve. The result cannot establish pure tocotrienol efficacy or justify extrapolation to any vitamin E supplement.

Condition and setting

incompletely_classified_hair_loss

Cautions

  • Small trial and mixed preparation; limited long-term safety evidence. NIH warns that high-dose supplemental vitamin E, particularly alpha-tocopherol, can increase bleeding risk and interact with anticoagulants/antiplatelets; do not transfer that risk estimate to every tocotrienol dose as though proven identical.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The study tested a specific mixture containing tocotrienols and alpha-tocopherol, not every vitamin E supplement.

Evidence, limits and sources for Mixed tocotrienols with alpha-tocopherol

What was found

Oral capsules each containing 50 mg mixed tocotrienols plus 23 IU alpha-tocopherol, twice daily for eight months. Thirty-eight adults entered, 35 completed; 36 were men. Hair-loss diagnoses were not rigorously stratified.

What this does not show

Small combination trial with insufficient diagnostic stratification. Tocotrienols cannot be isolated from the co-administered tocopherol; no generic vitamin E regrowth claim. The overall treatment main effect was nonsignificant; authors reported a positive month-eight between-group pairwise comparison.

Exact ingredient

The study tested a specific mixture containing tocotrienols and alpha-tocopherol, not every vitamin E supplement.

Why we included it

Makes a positive pilot interpretable without merging vitamin E forms.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Four-essential-oil scalp blend

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Thymus vulgaris; Rosmarinus officinalis; Lavandula angustifolia; Cedrus atlantica · Four essential oils in jojoba and grapeseed carrier oils

Form
Studied thyme, rosemary, lavender and cedarwood blend; not individual oils or culinary herbs
How it is used
topical
Evidence
Limited clinical evidence; older small combination trial

Photographic improvement occurred in 19/43 active versus 6/41 control patients. Evidence belongs to the blend and AA population, not any individual oil or AGA. The report does not establish modern comparative effectiveness.

Condition and setting

alopecia_areata

Cautions

  • Essential-oil sensitivity/irritation is possible; no home-mixing recipe is justified. Jojoba and grapeseed were carriers, including in the control group, not independently proven regrowth ingredients.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The combined essential oils and carriers were studied together. Whole thyme herb and the individual oils are not equivalent to that blend.

Evidence, limits and sources for Four-essential-oil scalp blend

What was found

The four essential oils in jojoba/grapeseed carrier oils, used topically with daily massage, versus carrier oils with massage; 86 AA patients randomized for seven months.

What this does not show

Evidence belongs to the blend and AA, not single oils, carriers or male-pattern AGA. Do not convert the historical formulation into a home recipe.

Exact ingredient

The combined essential oils and carriers were studied together. Whole thyme herb and the individual oils are not equivalent to that blend.

Why we included it

Prevents combination and AA results being assigned to individual oils or AGA.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Onion juice: topical research reference

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Allium cepa · Crude juice from the bulb

Form
Historical topical crude-juice study; no standardized retail product or home recipe validated
How it is used
topical
Evidence
Very limited clinical evidence; small study with weak design reporting

The small study reported regrowth in 20/23 active participants at six weeks and 2/15 controls at eight weeks. These differently timed figures must not be presented as a same-time response comparison. The abstract does not establish robust randomization or credible blinding.

Condition and setting

alopecia_areata

Cautions

  • No established preparation standard, poor generalizability, and irritation concerns. Do not provide raw-onion scalp instructions, claim benefit for AGA, or infer pediatric recommendation from enrollment of children.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. Topical onion juice is a different preparation and route from eating onions.

Evidence, limits and sources for Onion juice: topical research reference

What was found

Crude onion juice applied topically twice daily for two months versus tap water; 38 AA patients, including children, with 23 active and 15 control.

What this does not show

Small study; robust randomization and blinding are not established by the abstract. Active/control response figures are reported at different times. No AGA or pediatric-use inference.

Exact ingredient

Topical onion juice is a different preparation and route from eating onions.

Why we included it

Corrects a common online DIY claim using the actual small study.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Symptom support

Garlic gel: adjunctive research reference

Symptom research preparation reference symbol; no product shown
Symptom research preparation reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Allium sativum · Garlic preparation incorporated into a formulated gel

Form
Manufactured 5% garlic gel added to 0.1% betamethasone treatment
How it is used
topical
Evidence
Limited adjunctive evidence; small trial

Hair-count/clinical-response measures favored the adjunctive garlic-gel group. The trial did not test garlic alone, raw garlic, oral garlic, or AGA.

Condition and setting

alopecia_areata

Cautions

  • NCCIH warns that fresh raw garlic on skin can cause severe irritation and chemical burns. No recipe or occlusive application instructions should be supplied, even though the historical trial used a supervised protocol.

Why no exact ingredient link?

No single-material ingredient entry represents this exact research preparation. The trial gel was used alongside a corticosteroid. Culinary garlic and garlic oil are different preparations.

Evidence, limits and sources for Garlic gel: adjunctive research reference

What was found

A manufactured 5% garlic gel added to 0.1% betamethasone treatment, compared with placebo gel plus the same corticosteroid, for three months; 40 AA patients in a double-blind randomized study.

What this does not show

Both groups received a corticosteroid. This is not evidence for garlic alone, raw garlic, oral garlic or AGA.

Exact ingredient

The trial gel was used alongside a corticosteroid. Culinary garlic and garlic oil are different preparations.

Why we included it

Preserves adjunctive evidence and gives a prominent raw-garlic burn warning.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Support during care

Biotin (vitamin B7)

Engraved almond branch showing fruit, a split hull, shell and an edible kernel.
Ingredient reference illustration: Biotin Vitamin B7. Studied form: Dietary biotin or oral deficiency replacement; not a general regrowth dose. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Essential vitamin; not a plant part

Form
Dietary biotin or oral deficiency replacement; not a general regrowth dose
How it is used
oral
Evidence
Deficiency context; inadequate evidence for routine regrowth supplements

Deficiency can cause thinning/body-hair loss, but is rare. NIH finds little support for the broad hair/skin/nail claims made for supplements.

Condition and setting

documented_biotin_deficiency

Cautions

  • Extra biotin can produce falsely high or low laboratory results, including hormone tests. Users should disclose it before testing and follow the clinician/laboratory’s instructions, rather than a universal washout interval.

Read full ingredient card: Biotin Vitamin B7

Evidence, limits and sources for Biotin (vitamin B7)

What was found

Dietary biotin or oral replacement when deficiency is established; no evidence-based general hair-growth dose is supported.

What this does not show

Deficiency is uncommon; no general hair-growth dose or routine benefit in biotin-replete people is established.

Exact ingredient

The nutrient is biotin; the hair-related claim is restricted to established deficiency.

Why we included it

Common hair-vitamin claim has a clinically important laboratory-test caveat.

Sources

Support during care

Iron: deficiency replacement reference

An unlabelled closed amber bottle with an ivory child-resistant lid
Ingredient reference illustration: Iron: deficiency replacement. Studied form: Clinician-selected oral iron replacement after documented deficiency; salts differ in elemental content. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Elemental nutrient supplied by food or a labeled iron compound

Form
Clinician-selected oral iron replacement after documented deficiency; salts differ in elemental content
How it is used
oral
Evidence
Deficiency context; not evidence for treating hereditary alopecia

Iron inadequacy can contribute to hair loss; treating a confirmed deficiency addresses a potential cause, without guaranteeing regrowth or treating hereditary loss.

Condition and setting

documented_iron_deficiency

Cautions

  • Excess supplementation can cause gastrointestinal effects and poisoning; iron overload disorders require particular caution. Iron deficiency also warrants evaluation of its cause rather than indefinite self-treatment.

Read full ingredient card: Iron: deficiency replacement

Evidence, limits and sources for Iron: deficiency replacement reference

What was found

Oral iron replacement is clinician-selected when testing shows deficiency; ferrous/ferric salts differ in elemental iron content. There is no universal hair-regrowth dose or ferritin target here.

What this does not show

No general hair-regrowth dose or universal ferritin target is established; address the reason for iron deficiency.

Exact ingredient

This refers to targeted iron replacement after assessment. Iron-containing foods and concentrated supplements have different roles.

Why we included it

Identifies a remediable deficiency without promoting unsupervised iron.

Sources

Support during care

Zinc

Engraved study of Lentils (KJV lentiles). Source-plant study: Lentils (KJV lentiles)
Ingredient reference illustration: Zinc. Studied form: Food intake or clinician-directed oral zinc replacement. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Essential mineral; not a plant part

Form
Food intake or clinician-directed oral zinc replacement
How it is used
oral
Evidence
Deficiency context; no general growth-boosting claim

NIH states that zinc deficiency can cause hair loss and correction may help; extra zinc does not thereby make hair longer or thicker in zinc-replete people.

Condition and setting

documented_zinc_deficiency

Cautions

  • High intakes can cause nausea and other gastrointestinal symptoms; 50 mg/day or more for weeks can impair copper absorption. The US adult upper limit is 40 mg/day from all sources outside medically supervised treatment. Zinc can interact with some antibiotics and penicillamine.

Read full ingredient card: Zinc

Evidence, limits and sources for Zinc

What was found

Adequate food intake or clinician-directed oral replacement; no single studied formulation warrants a general hair-growth dose.

What this does not show

Correcting deficiency does not show that extra zinc improves hair in zinc-replete people.

Exact ingredient

This refers to zinc nutrition or replacement when deficient, not routine high-dose supplementation.

Why we included it

Balances deficiency context with avoidable high-dose copper depletion.

Sources

Tradition and early research

These historical reports or laboratory findings do not establish a clinical benefit.

Early lab research

Peppermint essential oil

Engraved study of Peppermint leaf. Source-plant study: Peppermint leaf
Ingredient reference illustration: Peppermint essential oil. Studied form: Topical essential-oil preparation in a mouse study; not a validated human formulation. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Mentha × piperita · Distilled flowering aerial parts including leaves

Form
Topical essential-oil preparation in a mouse study; not a validated human formulation
How it is used
topical
Evidence
Preclinical animal evidence only for the cited hair experiment

Hair-growth and follicular changes in mice are a research signal, not demonstrated human AGA treatment or proof of superiority to minoxidil in people. Do not convert the animal concentration into a human scalp recipe.

Condition and setting

animal_model_not_human_alopecia

Cautions

  • NCCIH reports skin rash/irritation with topical peppermint oil. The phrase “without toxic signs” in the animal paper’s title does not establish human safety.

Read full ingredient card: Peppermint essential oil

Evidence, limits and sources for Peppermint essential oil

What was found

3% topical peppermint oil in a four-week C57BL/6 mouse experiment, alongside saline, jojoba, and 3% minoxidil groups.

What this does not show

A shaved-mouse experiment cannot establish treatment efficacy, human safety or superiority to minoxidil in people.

Exact ingredient

The material is peppermint essential oil. The cited hair research is in animals; peppermint leaf preparations are different.

Why we included it

Prevents animal evidence being advertised as human treatment.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Safety and no-benefit findings

These records explain what to avoid or why a proposed benefit is not established.

Safety reference

Selenium: excess-intake safety

Engraved source or material study: three Brazil nuts with one opened shell.
Ingredient reference illustration: Selenium. Studied form: Dietary/supplemental selenium; not selenium-sulfide shampoo. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Essential trace mineral

Form
Dietary/supplemental selenium; not selenium-sulfide shampoo
How it is used
oral
Evidence
Established excess-intake safety concern

Chronic excess selenium can itself cause hair loss and brittle/lost nails. A selenium-containing “hair vitamin” is not automatically beneficial.

Condition and setting

supplement_excess_associated_hair_loss

Cautions

  • Supplement stacking and regularly large Brazil-nut intakes can produce excess. US and European upper limits differ, so do not present either as a target dose. No blanket avoidance of ordinary selenium-containing foods is implied.

Read full ingredient card: Selenium

Evidence, limits and sources for Selenium: excess-intake safety

What was found

Dietary/supplemental selenium exposure; not selenium-sulfide medicated shampoo, which is a different preparation and indication.

What this does not show

Safety entry only; selenium-sulfide shampoos are different products, and upper intake limits are not dosing targets.

Exact ingredient

The material is selenium; this is an excess-intake safety note.

Why we included it

Some supplements promoted for hair can themselves worsen hair loss.

Sources

Safety reference

Vitamin A: excess-intake safety

Engraved carrot root with a leafy top; a food source of provitamin A carotenoids.
Ingredient reference illustration: Vitamin A. Studied form: Oral preformed-vitamin-A excess; distinguish food carotenoids. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Preformed vitamin A; retinol and retinyl esters

Form
Oral preformed-vitamin-A excess; distinguish food carotenoids
How it is used
oral
Evidence
Established excess-intake safety concern

AAD links excessive vitamin A intake with worsening hair loss. This is a reason to review supplement labels, not evidence that eliminating vitamin-A foods treats alopecia.

Condition and setting

supplement_excess_associated_hair_loss

Cautions

  • High preformed vitamin A can cause systemic toxicity and birth defects. High-dose beta-carotene supplements carry separate risks for smokers/former smokers; food carotenoids and retinol supplements are not interchangeable.

Read full ingredient card: Vitamin A

Evidence, limits and sources for Vitamin A: excess-intake safety

What was found

Excess oral preformed vitamin A, especially supplements; distinguish from ordinary provitamin-A carotenoids in vegetables.

What this does not show

Safety entry only; do not equate ordinary carotenoid-containing foods with high-dose preformed supplements.

Exact ingredient

This safety note concerns excessive preformed vitamin A, which differs from carotenoid food sources.

Why we included it

A common nutrient can harm hair when taken in excess.

Sources

Safety reference

Fo-ti / He Shou Wu: safety reference

A whole dark woody tuberous root and a climbing leafy flowering Fo-ti sprig
Ingredient reference illustration: Fo-ti / He Shou Wu: safety. Studied form: Oral root preparations, extracts and teas; products and processing differ. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Pleuropterus multiflorus (syn. Polygonum multiflorum) · Root

Form
Oral root preparations, extracts and teas; products and processing differ
How it is used
oral
Evidence
Traditional hair claims; clinically documented liver-injury risk

NIH LiverTox describes traditional use and unproven controlled-trial efficacy, alongside numerous reports of clinically apparent liver injury, occasionally severe or fatal.

Condition and setting

traditional_hair_claims_with_liver_injury_risk

Cautions

  • Do not present “processed,” “natural,” or “traditional” as assurance against liver injury. A liver-injury warning must remain prominent; do not supply a preparation recipe or position this as a safe alternative to standard care.

Read full ingredient card: Fo-ti / He Shou Wu: safety

Evidence, limits and sources for Fo-ti / He Shou Wu: safety reference

What was found

Root extracts in oral products/teas have traditional hair-graying uses; commercial hair products vary. No established effective hair-loss preparation or dose can be supplied.

What this does not show

Traditional use is not evidence of effective hair-loss treatment; processing or a natural label does not establish liver safety.

Exact ingredient

This refers to Fo-ti root preparations and their liver-safety concerns. Other roots are not equivalent.

Why we included it

Traditional hair marketing requires a prominent serious liver-injury warning.

Sources

Safety reference

Creatine monohydrate: hair-loss concern

An open ivory container of white powder with a plain pewter-rimmed lid
Ingredient reference illustration: Creatine monohydrate. Studied form: Oral creatine monohydrate; the hair study used 5 g/day for 12 weeks. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Manufactured creatine monohydrate; not a plant part

Form
Oral creatine monohydrate; the hair study used 5 g/day for 12 weeks
How it is used
oral
Evidence
Limited short-term randomized safety evidence

A small 12-week trial found no creatine-related difference in measured hair outcomes or DHT compared with placebo.

Condition and setting

supplement_hair_loss_concern_in_healthy_trained_men

Cautions

  • New or progressive hair loss still deserves a cause-specific assessment.
  • This record addresses a hair-loss concern, not general clearance to use creatine with any condition or medication.

Read full ingredient card: Creatine monohydrate

Evidence, limits and sources for Creatine monohydrate: hair-loss concern

What was found

The study recruited 45 resistance-trained men aged 18–40; participants received creatine monohydrate or maltodextrin. Thirty-eight completed; 37 had hair assessments. No significant group-by-time differences appeared in hair metrics or androgen outcomes.

What this does not show

Short follow-up, small sample and one dose; family history of hair loss was not determined. This neither establishes hair regrowth nor excludes every long-term or individual risk.

Exact ingredient

The trial used oral creatine monohydrate, the same specific form described in the muscle-nutrition reference.

Why we included it

Answers a common concern spanning the muscle-mass and hair-loss topics without turning a short study into a universal safety promise.

Sources